Boston Scientific Corp. (NYSE:BSX) is adding two blocked artery treatment technologies two its portfolio of vascular treatment devices.
The Natick, Mass.-based medical device giant acquired a re-entry catheter from Israel-based S.I. Therapies Ltd. in November, and, with the pending acquisition of ReVascular Therapeutics Inc., the company is adding an intraluminal chronic total occlusions (CTO) crossing device. Both devices treat peripheral CTOs.
Sunnyvale, Calif.-based ReVascular’s RVT CTO Device won 510(k) market clearance from the Food & Drug Administration in January.
A CTO, or totally blocked artery, can not "typically be treated with standard endovascular devices such as guidewires and other catheter-based technologies," according to Boston Scientific. CTO treatment devices give doctors and patients the option of treating blocked arteries that might require surgery or amputation, the company said.
BSX made the acquisitions because the devices cover areas with promise of high growth potential, according to CEO Ray Elliott.
“Our [growth initiatives] include peripheral vascular disease, in which a significant number of patients remain undiagnosed or untreated. Addressing these challenges through use of less-invasive devices could greatly improve the care these patients receive,” he said in prepared remarks.
Here’s a roundup of companies announcing mergers, acquisitions and divestitures.
- Sonoma Orthopedic Products picks up NovaLign Orthopaedics assets
Sonoma Orthopedic Products Inc. closed the acquisition of certain key assets of NovaLign Orthopaedics Inc. The acquired intellectual property, assets and licenses relate to novel intramedullary designs for least invasive fracture fixation. Complementary to Sonoma’s proprietary WaviBody Technology, it is another type of flexible-to-rigid science that allows implants to be inserted into bones in a flexible condition and then locked securely to hold fractures in place during healing. The acquired technology will be marketed under the TaperBody brand. TaperBody implants can be inserted without violating surrounding joints and are especially useful for long bone fractures. Sonoma expects to begin rolling out TaperBody products in Q2 of this year.
Read more - Sciessent LLC acquires antimicrobial firm Agion Technologies
Sciessent LLC, is pleased to announce the acquisition of the assets of Agion Technologies Inc., a leader in providing antimicrobial and odor control solutions for the consumer, industrial and healthcare industries. Founded and led by the senior management team of the former Agion Technologies, Sciessent anticipates a seamless transition for Agion Technologies’ customers.
Read more - WellDoc takes over Oncology Care Home Health Specialists
WellDoc, a healthcare technology company focused on positive behavior change and supports clinical decision making to improve health outcomes and reduce healthcare costs, acquired Oncology Care Home Health Specialists Inc., the nation’s only home health consulting company dedicated to oncology. The acquisition is accelerating the development and quality of the WellDoc mHealth oncology solution, one of several disease suites in development, and will complement WellDoc’s FDA cleared DiabetesManager. This new subsidiary of WellDoc, now renamed Oncology Care Home Health LLC, is a comprehensive education and consulting company dedicated to helping home health providers implement specialized oncology programs.
Read more - BAE Systems completes purchase of L-1’s intelligence services group
BAE Systems Inc. completed its acquisition of L-1 Identity Solutions Inc.’s intelligence services group (ISG), which is comprised of SpecTal LLC, Advanced Concepts Inc., and McClendon LLC, for a purchase price of approximately $297 million. The completed transaction, initially announced in September, will enhance BAE Systems’ ability to effectively meet the growing needs of government intelligence, defense and security customers. ISG employs more than 1,000 people, who are suppliers to the U.S. intelligence and defense community and the company’s operations will now become an integral, complementary part of BAE Systems’ growing Intelligence & Security sector.
Read more
